Understanding vitiligo and its autoimmune mechanisms
P50-Admin Core-Harris/Garb
This study is looking into vitiligo, a skin condition that affects many people, especially those with darker skin, to better understand how it works and find new ways to treat it, and you might have a chance to help with this important research!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10868477 on NIH RePORTER |
What this research studies
This research focuses on vitiligo, an autoimmune skin disease affecting over 70 million people worldwide, particularly those with darker skin. It aims to explore the disease's pathogenesis using a multi-omics approach to uncover new signaling pathways involved in autoimmunity. By integrating various data points, the research seeks to provide a comprehensive understanding of vitiligo and its connection to other autoimmune diseases, ultimately leading to improved treatment strategies. Patients may have the opportunity to contribute to this innovative research that addresses significant health disparities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with vitiligo, especially those from diverse ethnic backgrounds.
Not a fit: Patients with other skin conditions unrelated to autoimmune mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for vitiligo and improve the quality of life for affected individuals.
How similar studies have performed: Previous research has shown promise in understanding autoimmune diseases through similar multi-omics approaches, indicating potential for success in this area.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Harris, John E — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Harris, John E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.